'en:aieop acute lymphoblastic leukemia protocol'
(id=6934562 ; fe=en:aieop acute lymphoblastic leukemia protocol ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=845 creation date=2017-06-25 touchdate=2025-05-13 07:30:32.000) ≈ 21 relations sortantes
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 36 / 1 ->
en:aieop all protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:aieop all protocol | rel=r_associated | relid=0 | w=36
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 32 / 0.889 ->
en:bmft-all protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:bmft-all protocol | rel=r_associated | relid=0 | w=32
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 31 / 0.861 ->
en:aieop 8803 high-risk all protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:aieop 8803 high-risk all protocol | rel=r_associated | relid=0 | w=31
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 31 / 0.861 ->
en:cyclophosphamide
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=31
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 30 / 0.833 ->
en:aieop 8801 low-risk all protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:aieop 8801 low-risk all protocol | rel=r_associated | relid=0 | w=30
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 30 / 0.833 ->
en:prednisone
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:prednisone | rel=r_associated | relid=0 | w=30
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 28 / 0.778 ->
en:all-bfm-90 protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:all-bfm-90 protocol | rel=r_associated | relid=0 | w=28
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 28 / 0.778 ->
en:cytarabine
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 27 / 0.75 ->
en:aieop 8802 standard-risk all protocol
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:aieop 8802 standard-risk all protocol | rel=r_associated | relid=0 | w=27
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 27 / 0.75 ->
en:antineoplastic combined chemotherapy protocols
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:antineoplastic combined chemotherapy protocols | rel=r_associated | relid=0 | w=27
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 27 / 0.75 ->
en:cisplatin/cyclophosphamide/etoposide
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:cisplatin/cyclophosphamide/etoposide | rel=r_associated | relid=0 | w=27
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 27 / 0.75 ->
en:daunorubicin
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:daunorubicin | rel=r_associated | relid=0 | w=27
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 27 / 0.75 ->
en:vincristine
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:vincristine | rel=r_associated | relid=0 | w=27
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 26 / 0.722 ->
en:asparaginase
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:asparaginase | rel=r_associated | relid=0 | w=26
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 26 / 0.722 ->
en:mercaptopurine
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:mercaptopurine | rel=r_associated | relid=0 | w=26
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 26 / 0.722 ->
en:methotrexate
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:methotrexate | rel=r_associated | relid=0 | w=26
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 26 / 0.722 ->
leucémie
n1=en:aieop acute lymphoblastic leukemia protocol | n2=leucémie | rel=r_associated | relid=0 | w=26
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 20 / 0.556 ->
asparaginase
n1=en:aieop acute lymphoblastic leukemia protocol | n2=asparaginase | rel=r_associated | relid=0 | w=20
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 20 / 0.556 ->
cyclophosphamide
n1=en:aieop acute lymphoblastic leukemia protocol | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 20 / 0.556 ->
daunorubicine
n1=en:aieop acute lymphoblastic leukemia protocol | n2=daunorubicine | rel=r_associated | relid=0 | w=20
- en:aieop acute lymphoblastic leukemia protocol --
r_associated #0: 3 / 0.083 ->
en:therapeutic or preventive procedure
n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=3
| ≈ 33 relations entrantes
- daunorubicine ---
r_associated #0: 75 -->
en:aieop acute lymphoblastic leukemia protocol
n1=daunorubicine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=75
- cyclophosphamide ---
r_associated #0: 71 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cyclophosphamide | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=71
- en:daunorubicin ---
r_associated #0: 71 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:daunorubicin | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=71
- en:cyclophosphamide ---
r_associated #0: 69 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:cyclophosphamide | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=69
- asparaginase ---
r_associated #0: 51 -->
en:aieop acute lymphoblastic leukemia protocol
n1=asparaginase | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=51
- en:asparaginase ---
r_associated #0: 51 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:asparaginase | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=51
- en:all-bfm-90 protocol ---
r_associated #0: 32 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:all-bfm-90 protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=32
- en:bmft-all protocol ---
r_associated #0: 32 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:bmft-all protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=32
- en:aieop 8801 low-risk all protocol ---
r_associated #0: 30 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:aieop 8801 low-risk all protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=30
- en:aieop 8802 standard-risk all protocol ---
r_associated #0: 27 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:aieop 8802 standard-risk all protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=27
- en:aieop 8803 high-risk all protocol ---
r_associated #0: 27 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:aieop 8803 high-risk all protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=27
- en:aieop all protocol ---
r_associated #0: 26 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:aieop all protocol | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=26
- en:antineoplastic combined chemotherapy protocols ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:antineoplastic combined chemotherapy protocols | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:cisplatin/cyclophosphamide/etoposide ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:cisplatin/cyclophosphamide/etoposide | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:cytarabine ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:cytarabine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:mercaptopurine ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:mercaptopurine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:methotrexate ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:methotrexate | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:prednisone ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:prednisone | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- en:vincristine ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:vincristine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- leucémie ---
r_associated #0: 20 -->
en:aieop acute lymphoblastic leukemia protocol
n1=leucémie | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
- cyclope (oeil) ---
r_associated #0: 15 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cyclope (oeil) | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=15
- Asparaginase ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=Asparaginase | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- Cyclophosphamide ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=Cyclophosphamide | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- Daunorubicine ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=Daunorubicine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- cytarabine ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cytarabine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- en:cyclops eye ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=en:cyclops eye | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- mercaptopurine ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=mercaptopurine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- méthotrexate ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=méthotrexate | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- prednisone ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=prednisone | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- vincristine ---
r_associated #0: 10 -->
en:aieop acute lymphoblastic leukemia protocol
n1=vincristine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=10
- cyclopeptide ---
r_associated #0: 5 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cyclopeptide | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=5
- cyclophiline ---
r_associated #0: 5 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cyclophiline | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=5
- cyclophorie ---
r_associated #0: 5 -->
en:aieop acute lymphoblastic leukemia protocol
n1=cyclophorie | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=5
|